Cyclooxygenase (COX) exists as two isoforms: COX-1, which is constitutively expressed in most cell types; and COX-2, which is inducible by lipopolysaccharide (LPS) and cytokines in a variety of cell types. Although previous studies have implicated two DNA binding proteins, interferon regulatory factor (IRF)-1 and IRF-2, in the regulation of LPS-and IFN-g-induced COX-2, their effects in vivo and in vitro are not well-defined. Using real-time PCR, COX-2 gene expression in the livers and lungs of mice challenged in vivo and in macrophages stimulated with LPS in vitro was investigated in wild-type and in IRF-1 and IRF-2 knockout mice. In response to 35 mg/kg LPS, IRF-1-, but not IRF-2-deficient mice, exhibited much poorer induction of COX-2 gene expression in both the livers and lungs. In vitro, COX-2 mRNA levels were also poorly induced in IRF-1-deficient macrophages, while IRF-2deficient macrophages exhibited higher levels than in normal macrophages. IRF-1 and IRF-2 were confirmed to activate and repress expression of the COX-2 promoter, respectively, in a transient transfection system and the role of specific DNA binding sites confirmed by site-specific mutagenesis. Collectively, these data provide evidence for an important role for IRF-1 in vivo and in vitro and for IRF-2 in vitro in the regulation of COX-2 expression by LPS.
INTRODUCTION
LPS is the principal component of the outer membrane of Gram-negative bacteria. Humans have evolved to detect low levels of LPS and respond by expressing a variety of inflammatory cytokines to combat infection. However, over-reaction to the presence of LPS during Gram-negative infection can lead to a systemic inflammatory response syndrome associated with sepsis. 1 Despite much effort, there is no good therapy for sepsis or septic shock. LPS can trigger multiple intracellular signaling pathways from the cell surface to the nucleus that activate protein tyrosine kinases, mitogen-activated protein kinases, ceramide-activated protein kinase, and others. 2 Those signaling pathways, in turn, activate a variety of transcription factors, which drive the transcription of many genes.
LPS is a potent stimulus for prostaglandin (PG) synthesis. 3 PGs are involved in numerous homeostatic biological functions and inflammation in almost all organs. PGs are formed by most cells and act as autocrine and paracrine lipid mediators. PGs are not stored, but are synthesized de novo from membrane-released arachidonic acid when cells are activated by mechanical trauma or by specific cytokines, growth factors, and other stimuli, including LPS. Arachidonic acid is released mainly by cytosolic phospholipase (cPLA 2 ), and is then acted upon by prostaglandin H synthase (PGHS; also referred to as 'COX', for cyclooxygenase). COX enzymatic activity is a rate-limiting step in PG production. 4 Two isoforms of this enzyme have been identified and are referred to as COX-1 and COX-2. Under most circumstances, COX-1 is produced constitutively, whereas COX-2 can be induced by several physiological stimuli and is expressed at sites of inflammation. 5 Although these isozymes catalyze identical reactions, they are often regulated by different signaling systems.
Interferons (IFNs) are a family of multifunctional, secreted proteins involved in antiviral defense, cell growth regulation, and immune activation. 6, 7 Typically, the type I IFNs (IFN-a and IFN-b) are produced by virus-infected host cells and constitute the primary response against virus infection, whereas type II (IFN-g), a TH1 cytokine produced primarily by activated T-cells and natural killer (NK) cells, is crucial in eliciting the proper immune response and pathogen clearance. Both play critical roles in response to LPS sensitivity. [8] [9] [10] IFNs elicit their effects through the transcriptional activation of target genes that possess specific consensus recognition sites, termed IFN stimulated response element (ISRE) and gamma activated sequence (GAS) elements, within their promoters. These genes are regulated through the JAK-STAT signaling pathway and/or involve interferon regulatory factors (IRFs), a growing family of transcription factors with a broad range of activities. IRF-1 and IRF-2 are two members of the IRF family. IRF-1 and IRF-2 were originally characterized as trans-activating and trans-repressing DNA binding proteins, respectively, although more recent studies have suggested that the latter is not always the case for IRF-2. 11 LPS can trigger several signaling pathways that activate transcription factors known to contribute to COX-2 expression, [12] [13] [14] [15] [16] [17] such as NF-kB, Sp-1, AP-2, and CREB. Our previous work, 18 and that of others, 19, 20 showed that COX-2 can be induced by LPS and IFN-g in primary murine macrophages. This is dependent on the expression of IRF-1, and requires the presence of two novel ISREs that are localized in the promoter of the murine COX-2 gene and conserved in the human COX-2 gene. IRF-1 and IRF-2 generally compete for binding at the same DNA locus and can act as mutual antagonists. However, Lohoff et al. 11 recently suggested that IRF-2 may act as a functional agonist rather than antagonist of IRF-1 in the regulation of some, but not all, genes involved in the differentiation of Th cells. In a mouse model of cerebral ischemia, [21] [22] [23] a decrease in PG release secondary to attenuated COX-2 production was proposed to contribute to the decrease in the ischemic injury observed in IRF-1 knockout mice and a role for COX-2 and PG in the inflammatory response has been associated with septic shock. [24] [25] [26] [27] [28] However, how the COX-2 gene is regulated by IRF-1 and IRF-2 and whether IRF-2 plays a role in attenuating COX-2 expression after LPS exposure are largely unanswered questions. To address these issues, quantitative, real-time PCR was used to examine COX-2 mRNA expression in mice with targeted mutations in IRF-1 or IRF-2 after LPS administration in vivo and their macrophages were examined in vitro for their responses to LPS. Our data indicate that IRF-1 plays a critical role in the induction and maintenance of COX-2 expression after LPS, but that IRF-2 does not play a critical role in attenuating COX-2 expression in LPS induction in vivo. In vitro, both IRF-1 and IRF-2 were found to regulate macrophage COX-2 gene expression and transfection experiments and sitespecific mutagenesis demonstrate the importance of specific sequences within the two ISREs contained within the COX-2 promoter for binding of IRF-1.
MATERIALS AND METHODS

Mice
All animals were housed in cages with filter tops in a laminar-flow hood, fed food and acid water ad libitum, and bred in a virus-free facility, as determined by a lack of antibody titers in sentinel mice. Mice with a targeted mutation in the IRF-1 or IRF-2 gene (homozygous [-/-] mice and their heterozygous [-/+] litter mates) were originally obtained from Dr Tak Mak (Amgen Institute, Toronto, Canada) and had been backcrossed to C57BL/6 mice 3-5 times when we received the breeding pairs. Inbred colonies of IRF-1 -/and IRF-2 -/mice have been maintained at the Uniformed Services University of the Health Sciences since 1996. Background-matched, IRF-1 +/+ and IRF-2 +/+ mice derived from heterozygotic mice were used as controls in these experiments. All mice bred for use in this study were genotyped. Male and female mice were used typically between 6-12 weeks of age. For temporal analysis of COX-2 expression in the liver and lung, the mice were injected i.p. with 35 mg/kg of LPS. In these experiments, groups of 4 mice were used for each time point. Experiments were carried out according to the institutional ethical guidelines for animal experiments and safety guidelines for gene manipulation experiments.
Tissue culture
Peritoneal macrophages were isolated 4 days after i.p. injection of mice with 3 ml sterile 3% thioglycollate broth. Cells were washed and resuspended in RPMI 1640 supplemented with 2 mM L-glutamine, 100 IU/ml penicillin, 100 mg/ml streptomycin, 10 mM HEPES, 0.3% sodium bicarbonate, and 2% FCS. Cells were plated in 6-well plates (4 x 10 6 cells/well) and incubated overnight at 37°C and 6% CO 2 . Cultures were washed twice with PBS to remove non-adherent cells, and treated with the indicated concentrations of LPS. Protein-free (< 0.008%), phenol/waterextracted Escherichia coli K235 LPS was prepared by the method of McIntire et al. 29 The CHO-K1 cell line, kindly provided by Dr Pei-hua Dai, Department of Biochemistry, USUHS, was cultured in HAM's F12 medium supplemented with 2 mM L-glutamine, 100 IU/ml penicillin, 100 mg/ml streptomycin and 10% FCS, and incubated as described above.
Preparation of total RNA and cDNA
Total RNA from cultured macrophages or from the livers and lungs of individual LPS-treated mice was isolated using RNA-Stat60 (Tel-Test) according to the manufacturer's instructions. The extracted RNA was precipitated with isopropanol at -20°C and dissolved in DEPC-treated distilled water. The isolated RNA (1 mg) was first treated with 1 U of amplification grade DNase I (BRL) in 9 ml final volume. The reaction was performed at room temperature for 15 min, and DNase I was inactivated by addition of 1 ml of 25 mM EDTA solution and heat inactivation for 10 min at 65°C. cDNA synthesis was carried out using the ABI kit (N808-0234, TaqMan Reverse Transcription Reagents), in a final volume of 25 ml containing 5.5 mM MgCl 2 , 500 mM of each dNTP, 0.4 U/ml of RNase inhibitor, 2.5 mM of random hexamers, and 1.25 U/ml of MultiScribe reverse transcriptase. The following program for making cDNA was employed: 25°C for 10 min, 48°C for 30 min, 95°C for 5 min.
Quantification of mRNA
The primers and probe for the detection of mouse COX-2 mRNA were designed with Primer Express software from ABI (Applied Biosystems) based on GenBank sequence data (accession no. NM_011198). The sequences for the COX-2 primers and probe were as follows: sense 5% -TTCGGGAG-CACAACAGAGTG-3%(positions, 999-1018); antisense 5% -TAACCGCTCAGGTGTTGCAC-3% (positions, 1146R-1127R); and probe (including fluorescent end-label designations) 5% -6FAM-CAACTATTCCAAACCAGCAGACT-CATACTCATAGGA-TAMRA-3% (positions, 1061-1096). The sequences for the primers and probe corresponding to mouse ribosomal RNA were provided by ABI kit (TaqMan Ribosomal RNA control reagent, part number 4308329) and was used as a 'housekeeping' gene to normalize samples differences in total RNA levels. COX-2 mRNA and ribosomal cDNA levels were quantified by real-time PCR using an ABI prism 7700 sequence detector according to the manufacturer's instructions (ABI). Each sample was assayed in triplicate. TaqMan Universal PCR Master Mix buffer (part number 4304437) was also purchased from ABI. A standard for COX-2 detection was made with the pCRII-COX-2-500 plasmid containing COX-2 (649/1146) cDNA (a standard curve was constructed with 0.001-10 pg plasmid cDNA), while the standard for detection of ribosomal RNA was made with cDNA derived from untreated controls. Real-time PCR was performed in 25 ml reaction volumes. Aliquots of cDNA (20 ng or 0.2 ng) were used for measuring COX-2 or ribosomal RNA levels. The final concentrations of primers and probe for detection of COX-2 mRNA were 600 nM and 200 nM, respectively, and the final concentrations of primers and probe for ribosomal mRNA were 50 nM and 200 nM, respectively. Each COX-2 mRNA level was normalized against its own ribosomal control. One way analysis of variance with Tukey post hoc testing was performed on real-time PCR data. A P value < 0.05 was accepted as a statistically significant difference.
Plasmid construction and transfection
The IRF-1 expression vector, 12 IRF-2 expression vector, 30, 31 and PGHS-2 'long' luciferase reporter construct 32 were as described previously. The PGHS-2 (-43) reporter, which contains the basic promoter, initiator sequence, and 88 bp of untranslated region from the murine COX-2 gene, was also constructed as described previously. 18 The two fragments of COX-2 promoter were amplified from the 'long' plasmid by PCR with forward primer (-1862): 5% -ATACGCGTG-GACCAGGGAGGCCTCAG-3% and (-1412): 5% -ATA-CGCGTAGGCCCTGGGTGACATGG-3% , respectively, and common reverse primer (-982): 5% -ATCTCGAGGGGGT-GTGAGGATGGAGTAG-3% .
Two fragments and PGHS (-43) plasmid were cut with MluI and XhoI, and the fragments of -1862/-982 and -1412/-982 were inserted into PGHS (-43) plasmid for generating PGHS (-43 + I & II) and PGHS (-43 + II) constructs. The sequences of all reporter constructs were confirmed by sequencing analysis. For transfection, CHO-K1 cells were seeded the night before the experiment on 24well plates (2 x 10 4 cells/well). The next day, reporter plasmid (0.5 mg) and different concentrations of IRF-1 and IRF-2 expression vectors were co-transfected using SuperFect transfection reagent (Qiagen) (total plasmid DNA was 1 mg for each transfection well, using the empty vector, pcDNA3.1, for balancing the total DNA concentration/well) according to the manufacturer's instructions. After transfection (3 h), cells were incubated with fresh media for an additional 24 h. Luciferase activity and protein concentration were measured as described previously, 30 and the concentration of protein was used for normalization of the luciferase activity within each treatment.
Gel shift analysis of in vitro translated IRF-1 and oligonucleotides encompassing ISRE I and ISRE II
Gel shift analysis using oligonucleotide sequences corresponding to the two ISREs identified within the COX-2 promoter was carried out as described previously. 18 Each ISRE was subdivided into oligonucleotides that were used in the gel shift assays with either control rabbit reticulocyte lysates or IRF-1 translated in vitro as described previously. 30 The specific oligonucleotide sequences used in these studies are shown in Figure 5A .
RESULTS
Kinetics of LPS-induced COX-2 mRNA expression in vivo
Previous data from our laboratory demonstrated that both IRF-1 and IRF-2 knockout mice are more refractory to LPS-induced lethality than background-matched, wild-type controls: intraperitoneal injection of mice with 35 mg/kg E. coli K235 LPS kills approximately 80% of control mice, while 100% of IRF-1 -/and IRF-2 -/mice survived (unpublished observations). 33 We also showed previously, 18 using semi-quantitative RT-PCR measurements of hepatic mRNA, that IRF-1 knockout mice initially responded to a non-lethal dose of LPS (25 mg i.p.) to induce expression of hepatic COX-2 mRNA, but failed to sustain its expression over time when compared to normal mice. To investigate how COX-2 mRNA levels are modulated in IRF-1 and IRF-2 wild-type and knockout mice, total RNA was isolated from the livers and lungs of individual LPS-treated mice at the indicated time points and levels of COX-2 mRNA were quantified using real-time RT-PCR.
Basal levels of hepatic COX-2 mRNA were not detectable in livers of untreated mice (t = 0 h); however, in control IRF-1 +/+ or IRF-2 +/+ mice, COX-2 mRNA levels were dramatically increased within 1 h of injection with the lethal dose of LPS (35 mg/kg) and COX-2 mRNA levels remained elevated for 12 h (Fig. 1A,B ). In comparison to the IRF-1 +/+ response to LPS, IRF-1 -/mice responded to LPS with a significantly lower level of induction at all time points (P < 0.05), which declined to background levels by 3 h post-injection. In contrast, hepatic COX-2 mRNA synthesis in IRF-2 knockout mice was essentially normal after LPS challenge, with no significant differences observed at any time point. Similar trends were seen in mice injected with 25 mg/mouse, a dose of LPS that is rarely lethal in control mice (data not shown).
In comparison to the undetectable levels of COX-2 mRNA in livers of untreated mice (Fig. 1 , t = 0 h) and in untreated peritoneal macrophages (see below), COX-2 mRNA was expressed constitutively in the lungs of both normal and IRF-deficient strains ( Fig. 2A,B ; t = 0 h). The data derived from lungs of LPS-injected mice showed that the COX-2 mRNA peaked by 1 h, began to decline by 3 h post-LPS injection, but remained above background, even after 12 h post-injection, in both normal and IRF-2 -/mice. As was observed in the liver, pulmonary COX-2 mRNA levels in IRF-1 -/mice were much less inducible than in IRF-1 +/+ mice, with significant differences observed at 1, 3, and 6 h following LPS injection (P < 0.05). Similar trends were seen in mice challenged with 25 mg/mouse (data not shown). The pulmonary COX-2 mRNA response of IRF-2 null mice to LPS injection was not significantly different from that of wild-type controls at any time point, consistent with the observed hepatic response. Collectively, the data in Figures 1 and 2 confirm and extend our previous findings in IRF-1 knockout mice, 18 and indicate that IRF-1 is critical for both hepatic and pulmonary LPS-induced COX-2 gene expression in vivo, while IRF-2 appears not to be necessary for expression of COX-2 mRNA in vivo. 
Induction of COX-2 mRNA expression in peritoneal macrophages derived from IRF-1 and IRF-2 knockout mice
To explore further the possible role of IRF-1 and IRF-2 in the regulation of COX-2 expression, peritoneal macrophages were isolated from the IRF-1 and IRF-2 mice and were treated in vitro with LPS. Figure 3A shows that COX-2 mRNA expression is dramatically increased in normal IRF-1 +/+ macrophages stimulated with LPS, but not in IRF-1 -/macrophages. Peritoneal macrophages from IRF-2 +/+ and IRF-2 -/mice were also analyzed after in vitro treatment with an even broader LPS concentration range (Fig.  3B) . In contrast to the poor COX-2 mRNA expression seen in IRF-1-deficient macrophages, LPS increased COX-2 mRNA expression in IRF-2 knockout macrophages 2-3-fold above the response of control macrophages. These findings suggest that the COX-2 gene is normally up-regulated by IRF-1 and down-regulated by IRF-2 in peritoneal macrophages in response to LPS.
Transcriptional regulation of the COX-2 promoter by IRF-1 and IRF-2 in CHO-K1 cells
The promoter of the COX-2 gene has been widely studied, and many sites for the binding of transcriptional regulatory proteins have been reported as illustrated in Figure 4A . The promoter region designated as 'C' contains many IRF-1 and IRF-2, in LPS-induced cyclooxygenase-2 (COX-2) expression 385 motifs for factors that are activated by several LPSinducible signaling pathways and which contribute to the regulation of the expression of COX-2 gene after induction. [12] [13] [14] [15] [16] [17] In our previous study, we identified two additional upstream consensus sequences, designated ISRE I and ISRE II, that were found to bind IRF-1 and IRF-2 differentially after LPS and IFN-g stimulation. 18 Since the data shown thus far extend our previous findings and provide further support for a role for IRF-1 and IRF-2 in the regulation of COX-2 gene expression, we sought to dissect the capacity of the two ISREs to regulate transcription in the absence of the other potentially contributory DNA binding proteins. To do this, we constructed two reporter constructs, PGSH-2 (-43) I & II and PGSH-2 (-43) II, which lack region C, leaving only one or both of the ISRE sites. The constructs were transiently transfected into CHO-K1 cells with control empty vector, or IRF-1 or IRF-2 expression plasmids (Fig. 4B ). Transient expression of IRF-1 activated the PGSH-2 (-43) I & II and PGSH-2 (-43) II reporter constructs. Luciferase activity was significantly higher in the PGSH-2 (-43) I & II transfected cells when compared to the promoter of COX-2 gene that expresses ISRE II alone, suggesting that both ISREs are involved in transcriptional activation by their interaction with IRF-1. In contrast, expression of IRF-2 led to repression of luciferase activity on both plasmids to an equivalent extent. These transfection results suggest that ISRE I and ISRE II both contribute to COX-2 gene expression when IRF-1 is activated, while IRF-2 represses basal COX-2 gene expression through the ISREs.
Identification of nucleotide sequences within ISRE I and ISRE II that are necessary for IRF-1 binding
The results shown in Figure 4 and our previous studies support the hypothesis that ISRE I and ISRE II sites are necessary for IRF-1-dependent transactivation of the COX-2 promoter. The next series of experiments were designed to narrow down nucleotide sequences that are critical for the binding site for IRF-1 within these ISREs. To that end, in vitro translated IRF-1 or control rabbit reticulocyte lysates were used in a gel-shift analysis using a series of oligonucleotides generated from the original ISRE I or ISRE II sequences previously described ('long'; Fig. 5A ). In vitro translated IRF-1 bound specifically only to the ISRE oligonucleotides that represent the middle region of ISRE I and ISRE II (see arrows in ISRE I med, Fig. 5B, and ISRE II med, Fig. 5D ), as evidenced by the failure of the oligonucleotide probe to bind control reticulocyte lysates. Double point mutations along ISRE I med ( Fig. 5C ) completely disrupted IRF-1 binding to ISRE I. However, IRF-1 binding to ISRE II was only disrupted in the case of mut 1 (Fig. 5E ) and was augmented in the cases of mut 2 and mut 3. These data indicate that the binding site for IRF-1 in the COX-2 promoter is highly dependent on this subregion that is highly conserved between mouse and human. 18
DISCUSSION
COX-2 serves as an important early response to infection or injury, alerting the host's innate immune system to systemic changes and helping it prepare to respond. In IRF-1 and IRF-2, in LPS-induced cyclooxygenase-2 (COX-2) expression 387 Fig. 5 . Binding of IRF-1 to ISRE I or ISRE II oligonucleotides. In vitro translated IRF-1 or control rabbit reticulocyte lysates were used in gel-shift analyses using a series of oligonucleotides generated from the originally described 18 ISRE I or ISRE II sequences (designated as ISRE I or ISRE II 'long'; A). IRF-1 binding to ISRE I oligonucleotides ('up,' 'med', or 'down'; B) or to oligonucleotides containing site-specific mutations within ISRE I 'med' (C). IRF-1 binding to ISRE II oligonucleotides ('up', 'med', or 'down'; D) or to oligonucleotides containing site-specific mutations within ISRE II 'med' (E). general, COX-2 overexpression is associated with pathological conditions. 22 LPS can stimulate the COX-2 expression by initiating several signaling pathways that lead to the activation of multiple DNA binding proteins. However, LPS also induces other pro-inflammatory cytokines, e.g. IFN-a, IFN-b, and IFN-g 1, 34, 35 and IL-1, that, in turn, induce a second wave of additional transcription factors, e.g. IRF-1, NF-kB, or COX-2 itself. 1, 6, 18 At this time, it is unclear whether physiological and pathological conditions result in differential modification of DNA-binding proteins, affecting their ability to interact with COX-2 gene regulatory elements and modulate its expression. Thus, elucidation of COX-2 regulatory pathways will likely lead to the development of new anti-inflammatory agents that may be efficacious in sepsis and related syndromes.
The transcriptional regulation of COX-2 has been intensely studied this decade. However, IRF-1 and IRF-2 have only recently been implicated in COX-2 gene expression by LPS and IFN-g. 18 To define further a role for IRF-1 and IRF-2 in LPS-induced COX-2 expression, we combined two powerful approaches: (i) the use of real-time RT-PCR to quantify specific levels or COX-2 mRNA accurately and reproducibly; and (ii) utilizing mice with targeted mutations in either the IRF-1 or IRF-2 genes to determine their role in LPS-induced COX-2 gene expression in vivo and in vitro. RT-PCR is the most sensitive method for the detection of low-abundance mRNA, often obtained from limited tissue samples. However, it is a complex technique, and there are substantial problems associated with its true sensitivity, reproducibility, and specificity and, as a quantitative method, it suffers from the problems inherent in PCR. The recent introduction of fluorescence-based kinetic RT-PCR (real-time RT-PCR) procedures significantly simplifies the process of producing reproducible quantification of mRNAs and largely overcomes the limitations inherent to our previous analysis.
Using a dose of LPS that kills 80% of control mice, but none of the IRF-1 or IRF-2 knockout mice, we have shown in this report that LPS-induced COX-2 gene expression is a very early response in all strains tested. Although there were differences in the overall kinetics in the liver versus the lung, it is clear that IRF-1 plays a critical role in the induction and maintenance of COX-2 in response to this very high dose of LPS. Similarly, our data in vitro also demonstrate a clear-cut requirement for IRF-1 for COX-2 mRNA expression, but also reveal that IRF-2 also plays a role in the regulation of this gene's expression by LPS in macrophages. The finding that COX-2 mRNA levels are significantly elevated at all concentrations of LPS tested in the IRF-2 -/macrophages, indicates that IRF-2 functions as a normal repressor of this gene, and somehow becomes derepressed in response to LPS stimulation. These data are completely consistent with our previous findings, and solidify the role of IRF-1 and IRF-2 in vivo and reveal a more substantial role for IRF-2 in vitro through the quantitative analysis afforded by real-time RT-PCR. These data strongly support the hypothesis that IRF-1 serves an activator both in vivo and in vitro, while IRF-2 serves a repressor in the regulation of COX-2 gene expression induced by LPS in peritoneal macrophages and in CHO-K1 cells. However, it is interesting to note that in vivo, hepatic and pulmonary COX-2 mRNA are not significantly up-regulated in IRF-2 null mice, suggesting that additional transcription factors or cell types may compensate for the lack of IRF-2 in response to LPS in vivo.
Under most circumstances, COX-1 is produced constitutively, whereas COX-2 can be induced by several stimuli. COX-2 mRNA is undetectable under normal conditions in most cells and tissues. But in some organs, 22, 36, 37 COX-2 is expressed basally, e.g. brain, heart, and lung. Our quantitative RT-PCR data also revealed differential expression of basal COX-2 mRNA in mouse liver and lung, suggesting that COX-2 may contribute to homeostatic as well as pathophysiological conditions in a tissue-specific manner.
It has been suggested that diminished PG release secondary to attenuated COX-2 production in a mouse model of cerebral ischemia 21, 23 may contribute to the decrease in ischemic injury observed in IRF-1 -/mice and that this same mechanism may be operative in the inflammatory response to sepsis. Both the liver and lung are key 'shock' organs in bacterial sepsis, and damage to the liver has been reported in many models of endotoxicity and sepsis. [38] [39] [40] Our results clearly correlate diminished COX-2 expression with resistance to lethality that has been observed in IRF-1 knockout mice; however, our data fail to account for increased resistance to endotoxicity exhibited by IRF-2 knockout mice based on mitigated COX-2 expression. Studies are currently in progress to identify other mediators that are grossly dysregulated in the IRF-2 knockout mice that could account for their marked resistance to LPS in vivo.
LPS activates signaling via TLR4, resulting in the activation of multiple MAPK pathways. 1 These result directly or indirectly in the phosphorylation and activation various transcriptional factors, including Elk-1, Sp1, AP2, SRE, CREB, and NF-kB. Several studies [12] [13] [14] [15] [16] [17] have documented that the COX-2 promoter has binding sites for these various DNA-binding proteins. To address how the two ISREs participate in COX-2 regulation, all of the aforementioned binding sites were removed to generate two novel reporter constructs that contain the ISRE I and ISRE II or ISRE II only plus the basal transcriptional region (Fig. 5 ). After co-transfection with an IRF-1-expressing vector into CHO-K1 cells, luciferase activity increased 10-fold in the construct containing both ISRE I and ISRE II, compared to a 2-3-fold increase in the construct that contained only ISRE II. IRF-2 represses the basal luciferase activate of both constructs, although no differential could be established. The transfection results suggest that ISRE I and ISRE II synergize for IRF-1-dependent COX-2 expression, while IRF-2 represses the COX-2 expression through ISRE II. Furthermore, the mutational analysis presented in Figure  5 confirms that specific nucleotides within the two ISREs are critical for the binding of IRF-1. Collectively, these data provide additional molecular evidence that IRF-1 and IRF-2 regulate the COX-2 gene expression through two ISREs. However, how these IRFs co-operate with other factors to regulate COX-2 gene expression is still an open question, which when elucidated, will further our understanding of the role of COX-2 in normal and pro-inflammatory conditions.
